Rosa Dela, Elya Berna, Hanafi Muhammad, Khatib Alfi, Budiarto Eka, Nur Syamsu, Surya Muhammad Imam
Department of Pharmacy, Faculty of Pharmacy, Indonesia University, Depok, Indonesia.
Department of Pharmacy, Faculty of Health Science, Pelita Harapan University, Tangerang, Indonesia.
PLoS One. 2025 Jan 3;20(1):e0313592. doi: 10.1371/journal.pone.0313592. eCollection 2025.
One way to treat diabetes mellitus type II is by using α-glucosidase inhibitor, that will slow down the postprandial glucose intake. Metabolomics analysis of Artabotrys sumatranus leaf extract was used in this research to predict the active compounds as α-glucosidase inhibitors from this extract. Both multivariate statistical analysis and machine learning approaches were used to improve the confidence of the predictions. After performance comparisons with other machine learning methods, random forest was chosen to make predictive model for the activity of the extract samples. Feature importance analysis (using random feature permutation and Shapley score calculation) was used to identify the predicted active compound as the important features that influenced the activity prediction of the extract samples. The combined analysis of multivariate statistical analysis and machine learning predicted 9 active compounds, where 6 of them were identified as mangiferin, neomangiferin, norisocorydine, apigenin-7-O-galactopyranoside, lirioferine, and 15,16-dihydrotanshinone I. The activities of norisocorydine, apigenin-7-O-galactopyranoside, and lirioferine as α-glucosidase inhibitors have not yet reported before. Molecular docking simulation, both to 3A4A (α-glucosidase enzyme from Saccharomyces cerevisiae, usually used in bioassay test) and 3TOP (a part of α-glucosidase enzyme in human gut) showed strong to very strong binding of the identified predicted active compounds to both receptors, with exception of neomangiferin which only showed strong binding to 3TOP receptor. Isolation based on bioassay guided fractionation further verified the metabolomics prediction by succeeding to isolate mangiferin from the extract, which showed strong α-glucosidase activity when subjected to bioassay test. The correlation analysis also showed a possibility of 3 groups in the predicted active compounds, which might be related to the biosynthesis pathway (need further research for verification). Another result from correlation analysis was that in general the α-glucosidase inhibition activity in the extract had strong correlation to antioxidant activity, which was also reflected in the predicted active compounds. Only one predicted compound had very low positive correlation to antioxidant activity.
治疗II型糖尿病的一种方法是使用α-葡萄糖苷酶抑制剂,它会减缓餐后葡萄糖摄取。本研究采用对苏门答腊鹰爪叶提取物进行代谢组学分析,以预测该提取物中作为α-葡萄糖苷酶抑制剂的活性化合物。多元统计分析和机器学习方法均被用于提高预测的可信度。在与其他机器学习方法进行性能比较后,选择随机森林来建立提取物样品活性的预测模型。特征重要性分析(使用随机特征排列和Shapley分数计算)用于将预测的活性化合物识别为影响提取物样品活性预测的重要特征。多元统计分析和机器学习的联合分析预测出9种活性化合物,其中6种被鉴定为芒果苷、新芒果苷、去甲异紫堇定、芹菜素-7-O-吡喃半乳糖苷、鹅掌楸碱和15,16-二氢丹参酮I。去甲异紫堇定、芹菜素-7-O-吡喃半乳糖苷和鹅掌楸碱作为α-葡萄糖苷酶抑制剂的活性此前尚未见报道。分子对接模拟,针对3A4A(来自酿酒酵母的α-葡萄糖苷酶,通常用于生物测定试验)和3TOP(人肠道中α-葡萄糖苷酶的一部分),结果显示所鉴定的预测活性化合物与两种受体均有强至极强的结合,但新芒果苷仅与3TOP受体有强结合。基于生物测定导向分级分离的分离进一步验证了代谢组学预测,成功从提取物中分离出芒果苷,其在生物测定试验中表现出强α-葡萄糖苷酶活性。相关性分析还显示预测的活性化合物可能存在3组,这可能与生物合成途径有关(需要进一步研究验证)。相关性分析的另一个结果是,一般来说提取物中的α-葡萄糖苷酶抑制活性与抗氧化活性有很强的相关性,这在预测的活性化合物中也有体现。只有一种预测化合物与抗氧化活性有非常低的正相关性。